BioSpace News Archive

Business

GlycoMimetics Reports Fourth Quarter and Year-End 2017 Results

The Phase 3 trial of rivipansel remains on track for completion during the second half of 2018.

March 6, 2018
·
7 min read
Deals

Celgene Completes Acquisition of Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy

Advances strategy to become a leader in global cellular immunotherapy.

March 6, 2018
·
2 min read
Drug Development

Boehringer Ingelheim and Lilly expand heart failure program for Jardiance® with new exercise capacity trials

EMPERIAL clinical trials will evaluate the effect of Jardiance (empagliflozin) on exercise ability and heart failure symptoms in people with chronic heart failure; EMPERIAL is part of the most comprehensive clinical trial program of an SGLT2 inhibitor in chronic heart failure

March 6, 2018
·
12 min read
BioMidwest

Aptinyx Presents NYX-2925 Preclinical Data in Chemotherapy-induced Neuropathic Pain at the American Pain Society Annual Scientific Meeting

Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for challenging neurologic disorders, today announced their presentation at the American Pain Society’s Annual Scientific Meeting, March 4-6, 2018 in Anaheim, CA.

March 6, 2018
·
3 min read
Business

HIMSS Analytics Announces Collaboration to Advance Supply Chain Capacity in Global Health Systems

Through this unique initiative HIMSS Analytics will accelerate the development and launch of evidence-based tools to support supply chain transformation in global health systems.

March 6, 2018
·
2 min read
Pharm Country

Citius Reports Progress in Hemorroid Treatment Program

Selection of higher potency corticosteroid for Phase 2b Trial to improve efficacy and faster onset of symptomatic relief.

March 6, 2018
·
4 min read
Business

Disarm Therapeutics Expands Scientific Advisory Board with Experts in Neurology, Neuropathy, and Axonal Degeneration

Disarm Therapeutics, a biotechnology company creating a new class of disease-modifying therapeutics for patients with axonal degeneration, a central driver of neurological disease, today announced new Scientific Advisory Board (SAB) members.

March 6, 2018
·
4 min read
BioMidwest

Stryker introduces groundbreaking, post-free distraction system, designed to mitigate common groin complications associated with hip arthroscopy

Stryker announced today the launch of the industry’s first-ever, post-free hip distraction system, Pivot Guardian, designed to mitigate groin complications and heel slip associated with hip arthroscopy and improve patient outcomes.

March 6, 2018
·
2 min read
Job Trends

ESO Launches Surveillance Form for Overdose

Specialty Patient Form to help standardize definitions and data collection, highlight responder safety.

March 6, 2018
·
3 min read
Biotech Bay

TeraPore Technologies Raises $6M in Oversubscribed Series A Funding Round

Round led by Anzu Partners, and includes RA Capital Management and Artiman Ventures.

March 6, 2018
·
5 min read